Structural characterization of glycinamide-RNase-transformylase T from .
Clicks: 206
ID: 74558
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
69.8
/100
203 views
164 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Enzymes from the purine salvage pathway in () have been regarded as an attractive target for the development of anti-bacterial drugs. Although this pathway has not been extensively studied in , it has been identified as essential for growth and survival. Glycinamide-RNase-transformylase T (PurT) is found only in some specific bacteria including and utilizes ATP-dependent ligation to catalyze the formylation of 5'-phosphoribosyl-glycinamide (GAR) in the third reaction of the de novo purine salvage pathway. In the study, we determined the crystal structure of PurT at a resolution of 2.79 Å. In contrast to PurT (phBCCPPurT), PurT exhibits an "open" conformation, which results in a broader ATP-binding pocket and thus might facilitate the entry and exit of the cofactor. Additionally, active site superposition with PurT (PurT) showed that residues involved in the ATP-binding site in PurT exhibited structural similarity but had notable difference in the GAR-binding site. The loop 383-389 in PurT was much shorter and shifted 5.7 Å away from the phosphate of the GAR substrate. The different GAR-binding mode might result in a large conformational change in PurT, and would provide a possible opportunity for anti-TB drug development.
| Reference Key |
chen2020structuralemerging
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chen, Cong;Liu, Zuliang;Liu, Liguo;Wang, Jianmin;Jin, Qi; |
| Journal | emerging microbes & infections |
| Year | 2020 |
| DOI |
10.1080/22221751.2019.1707716
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.